SEC Form 4 · accession 0001487371-15-000087
GenMark Diagnostics, Inc. · GNMK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon Faiz Kayyem
Officer — SVP, Research & Development
Period of report
Jun 3, 2015
Accepted (ET)
Jun 5, 2015 · 6:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001487371
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 3, 2015 | S | 937 | $9.53 | D | 107,165 | D | |
| Common Stock | Jun 4, 2015 | S | 105 | $9.81 | D | 107,060 | D | |
| Common StockF2 | holding | — | — | — | 82,934 | I | The Jon Faiz Kayyem and Paige N. Gates Family Trust, dated April 1, 2000 | |
| Common StockF2 | holding | — | — | — | 61,651 | I | HI Charitable Remainder Uni Trust | |
| Common StockF2 | holding | — | — | — | 569,308 | I | IFIN LP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold pursuant to a Rule 10b5-1 trading plan solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock awards and/or units.
- F2Dr. Kayyem is the trustee of the HI Charitable Remainder Uni Trust, trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust, dated April 1, 2000 and the President of In-Motion LLC, the general partner of IFIN LP. Dr. Kayyem disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.